+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Digital Pathology Market Size, Share & Trends Analysis Report By Application (Drug Discovery & Development, By Product, Academic Research, Diagnosis), By End Use, And Segment Forecasts, 2019 - 2026

  • ID: 4599568
  • Report
  • Region: Global
  • 100 pages
  • Grand View Research
1 of 3

FEATURED COMPANIES

  • 3DHISTECH Ltd.
  • Danaher
  • Definiens
  • Digipath, Inc.
  • F. Hoffmann-La Roche Ltd
  • Hamamatsu Photonics, Inc.
  • MORE
The global digital pathology market size is expected to reach USD 1.67 billion by 2026, according to this report. It is anticipated to expand at a CAGR of 11.7% during the forecast period. Increasing prevalence of chronic diseases triggers the demand for advanced diagnostics, which is expected to drive the market growth. Growing economic stability and awareness pertaining to the benefits with the use of computer-aided diagnostics is further contributing to the growth.

Technological advancements such as digital imaging, computerization, robotic light microscopy, and multiple fiberoptic communications are some of the key factors driving the adoption of digital pathology. In addition, introduction of cloud-based technology enabling storage of digital slides coupled with secure access to pathologists is expected to serve as a potential growth driver for the market.

Digital pathology has important role in companion diagnostics and drug development pipeline, including molecular biology, biobanking, molecular tissue profiling, and tissue microarray analysis. Increasing demand for high-quality tissue samples in tissue-based biomarker research is expected to propel adoption of the technology over the forecast period.

The market is expected to witness intense competition in near future owing to rising adoption of rigorous strategies by the market players to sustain competition. For instance, whole slide imaging system manufacturers focus on obtaining premarket approval for diagnostic digital systems to capture greater revenue share.

Further key findings from the study suggest:
  • Devices held the dominant market share in 2018 owing to increased use in academic research
  • Rising implementation of slide management system in stratified medicine and tissue-based biomarker research is one of the key contributing factors for the dominance of this technology
  • Software segment is expected to witness lucrative growth in near future as the product assists in faster diagnosis and synchronization of patient data, where healthcare professionals can remotely access this information
  • Digital pathology is increasingly used in academic research owing to various benefits such as cost-effectiveness and rapid results
  • Disease diagnosis segment is expected to witness lucrative growth over the forecast period owing to the increasing prevalence of cancer and demand for noble diagnosis techniques
  • Availability of unified platforms for workflows in pathology is anticipated to boost the usage of computer-aided imaging technology in academic research, which is anticipated to boost the segment growth
  • Hospital led the end use segment in 2018 owing to the increasing adoption of these technologies across these facilities

Please note: This product will be delivered within 48 business hours after receipt of order.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • 3DHISTECH Ltd.
  • Danaher
  • Definiens
  • Digipath, Inc.
  • F. Hoffmann-La Roche Ltd
  • Hamamatsu Photonics, Inc.
  • MORE

Chapter 1 Methodology & Scope
1.1 Segment Market Scope
1.2 Market Definitions
1.3 Information procurement
1.3.1 Purchased database
1.3.2 GVR'S internal database
1.3.3 Secondary sources & third party perspectives
1.3.4 Primary research
1.3.5 Primary interview breakup
1.3.5.1 Data for primary interviews, by sources
1.3.5.2 Data for primary interviews, by region
1.3.5.2.1 North America
1.3.5.2.2 Europe
1.3.5.2.3 Asia Pacific
1.3.5.2.4 Latin America
1.3.5.2.5 MEA
1.4 Information analysis
1.4.1 Data analysis models
1.5 Market formulation & data visualization
1.6 Data validation and publishing

Chapter 2 Executive summary
2.1 Market outlook
2.2 Market Summary
2.3 Segment outlook
2.4 Competitive Insights

Chapter 3 Digital Pathology Market Variables, Trends & Scope
3.1 Market Lineage outlook
3.1.1 Parent market outlook
3.1.2 Related/ancillary market outlook
3.2 Penetration & Growth Prospect Mapping
3.3 Product Pipeline Analysis, by Stage
3.4 Industry Value Chain Analysis
3.4.1 Manufacturing Trends
3.4.1.1 Technology Trends
3.4.1.2 Outsourcing & Contract Manufacturing Trends
3.4.1.3 Cost Structure Analysis (To Include Cost Structure Analysis for Med Devices)
3.4.2 User perspective analysis
3.4.2.1 Consumer Behavior Analysis
3.4.2.2 Market Influencer Analysis
3.4.3 Procedure cost analysis/breakdown
3.4.4 List of Key End-users, by region / by product / by country (Applicable only for B2B products)
3.5 Technology Overview
3.5.1 Technology Timeline (Transition / various technology adoption past & future predictions)
3.6 Regulatory Framework
3.6.1 Reimbursement framework
3.6.2 Standards & Compliances
3.6.3 Safety
3.7 Market Dynamics
3.7.1 Market Driver Analysis
3.7.1.1 Increasing prevalence of chronic diseases
3.7.1.2 Rapid technological advancements
3.7.1.3 Greater cost efficiency
3.7.2 Market Restraint Analysis
3.7.2.1 Lack of Reimbursement
3.7.3 Industry Challenges
3.7.3.1 Pathologists are skeptical about the adoption of digital pathology
3.8 Digital Pathology Market Analysis Tools
3.8.1 Industry Analysis - Porter’s
3.8.1.1 Supplier Power
3.8.1.2 Buyer Power
3.8.1.3 Substitution Threat
3.8.1.4 Threat from new entrant
3.8.1.5 Competitive rivalry
3.8.2 PESTEL Analysis
3.8.2.1 Political landscape
3.8.2.2 Environmental landscape
3.8.2.3 Social landscape
3.8.2.4 Technology landscape
3.8.2.5 Legal landscape
3.8.3 Major Deals & Strategic Alliances Analysis
3.8.3.1 Joint Ventures
3.8.3.2 Mergers & Acquisitions
3.8.3.3 Licensing & Partnership
3.8.3.4 Technology Collaborations
3.8.3.5 Strategic Divestments
3.8.4 Market Entry Strategies
3.8.5 Case Studies
3.8.6 PRICE EROSION ANALYSIS

Chapter 4 Digital Pathology Market Competitive & Vendor Landscape
4.1 Participation Categorization
4.2 Strategic Initiatives & Outcome Analysis
4.2.1 LIST OF KEY STRATEGIES, BY COMPANY
4.3 List of Key Companies, by Region
4.3.1 List of Market Players, By region
4.4 Company Market Share Analysis, 2018
4.5 Vendor Landscape
4.5.1 LIST OF DISTRIBUTORS
4.6 Recent developments & impact analysis, by key market participants
4.7 Company/Competition Categorization (Key innovators, Market leaders, emerging players)
4.8 Vendor Landscape
4.8.1 List of key distributors and channel partners
4.8.2 Key customers
4.8.3 Key company market share analysis, 2018
4.9 Public Companies
4.9.1 Company market position analysis (Revenue, geographic presence, product portfolio, key serviceable industries, key alliances)
4.9.2 Company/ Model wise Volume Analysis, 2018 (case-to-case basis)
4.9.3 Company Market Share/Ranking, by region
4.9.4 Competitive Dashboard Analysis
4.9.4.1 Market Differentiators
4.9.4.2 Synergy Analysis: Major Deals & Strategic Alliances
4.9.5 Model Mapping/Who supplies Whom (Only Applicable for Automotive Title)
4.10 Private Companies
4.10.1 List of key emerging companies’ /technology disruptors/innovators
4.10.2 Funding Outlook (Optional)
4.10.3 Regional network map
4.10.4 Company market position analysis (geographic presence, product portfolio, key alliance, industry experience)
4.10.5 Supplier Ranking

Chapter 5 Digital Pathology Market: Product Estimates & Trend Analysis
5.1 Digital Pathology Market: Product Movement Analysis
5.2 Software
5.2.1 Software market estimates and forecasts, 2014 - 2026 (USD Million)
5.3 Device
5.3.1 Device market estimates and forecasts, 2014 - 2026 (USD Million)
5.3.2 Scanners
5.3.2.1 Scanners market estimates and forecasts, 2014 - 2026 (USD Million)
5.3.3 Slide management system
5.3.3.1 Slide management system market estimates and forecasts, 2014 - 2026 (USD Million)
5.4 Storage system
5.4.1 Storage System market estimates and forecasts, 2014 - 2026 (USD Million)

Chapter 6 Digital Pathology Market: Application Estimates & Trend Analysis
6.1 Digital Pathology Market: Application Movement Analysis
6.2 Drug Discovery & Development
6.2.1 Drug discovery & development market estimates and forecasts, 2014 - 2026 (USD Million)
6.3 Academic research
6.3.1 Academic research market estimates and forecasts, 2014 - 2026 (USD Million)
6.4 Disease Diagnosis
6.4.1 Disease diagnosis market estimates and forecasts, 2014 - 2026 (USD Million)
6.4.2 Cancer cell detection
6.4.2.1 Cancer cell detection market estimates and forecasts, 2014 - 2026 (USD Million)
6.4.3 Other applications
6.4.3.1 Other applications market estimates and forecasts, 2014 - 2026 (USD Million)

Chapter 7 Digital Pathology Market: End Use Estimates & Trend Analysis
7.1 Digital Pathology Market: End Use Movement Analysis
7.2 Hospitals
7.2.1 Hospitals market estimates and forecasts, 2014 - 2026 (USD Million)
7.3 Biotech & pharma companies
7.3.1 Biotech & pharma companies market estimates and forecasts, 2014 - 2026 (USD Million)
7.4 Diagnostic Labs
7.4.1 Diagnostic labs market estimates and forecasts, 2014 - 2026 (USD Million)
7.5 Academic & research institutes
7.5.1 Academic & research institutes market estimates and forecasts, 2014 - 2026 (USD Million)

Chapter 8 Digital Pathology Market: Regional Estimates & Trend Analysis, by Technology, Application & End Use
8.1 Digital Pathology Market Shares by Region, 2018 & 2026
8.2 North America
8.2.1 North America digital pathology market estimates and forecasts, 2014 - 2026 (USD Million)
8.2.2 U.S.
8.2.2.1 U.S. digital pathology market estimates and forecasts, 2014 - 2026 (USD Million)
8.2.3 Canada
8.2.3.1 Canada digital pathology market estimates and forecasts, 2014 - 2026 (USD Million)
8.3 Europe
8.3.1 Europe digital pathology market estimates and forecasts, 2014 - 2026 (USD Million)
8.3.2 U.K.
8.3.2.1 U.K. digital pathology market estimates and forecasts, 2014 - 2026 (USD Million)
8.3.3 Germany
8.3.3.1 Germany digital pathology market estimates and forecasts, 2014 - 2026 (USD Million)
8.3.4 France
8.3.4.1 France digital pathology market estimates and forecasts, 2014 - 2026 (USD Million)
8.3.5 Italy
8.3.5.1 Italy digital pathology market estimates and forecasts, 2014 - 2026 (USD Million)
8.3.6 Russia
8.3.6.1 Russia digital pathology market estimates and forecasts, 2014 - 2026 (USD Million)
8.3.7 Spain
8.3.7.1 Spain digital pathology market estimates and forecasts, 2014 - 2026 (USD Million)
8.3.8 Netherlands
8.3.8.1 Netherlands digital pathology market estimates and forecasts, 2014 - 2026 (USD Million)
8.3.9 Switzerland
8.3.9.1 Switzerland digital pathology market estimates and forecasts, 2014 - 2026 (USD Million)
8.3.10 Sweden
8.3.10.1 Sweden digital pathology market estimates and forecasts, 2014 - 2026 (USD Million)
8.4 Asia Pacific
8.4.1 Asia Pacific digital pathology market estimates and forecasts, 2014 - 2026 (USD Million)
8.4.2 Japan
8.4.2.1 Japan digital pathology market estimates and forecasts, 2014 - 2026 (USD Million)
8.4.3 China
8.4.3.1 China digital pathology market estimates and forecasts, 2014 - 2026 (USD Million)
8.4.4 India
8.4.4.1 India digital pathology market estimates and forecasts, 2014 - 2026 (USD Million)
8.4.5 Indonesia
8.4.5.1 Indonesia digital pathology market estimates and forecasts, 2014 - 2026 (USD Million)
8.4.6 Thailand
8.4.6.1 Thailand digital pathology market estimates and forecasts, 2014 - 2026 (USD Million)
8.4.7 Australia
8.4.7.1 Australia digital pathology market estimates and forecasts, 2014 - 2026 (USD Million)
8.4.8 South Korea
8.4.8.1 South Korea digital pathology market estimates and forecasts, 2014 - 2026 (USD Million)
8.4.9 Philippines
8.4.9.1 Philippines digital pathology market estimates and forecasts, 2014 - 2026 (USD Million)
8.4.10 Malaysia
8.4.10.1 Malaysia digital pathology market estimates and forecasts, 2014 - 2026 (USD Million)
8.4.11 Singapore
8.4.11.1 Singapore digital pathology market estimates and forecasts, 2014 - 2026 (USD Million)
8.5 Latin America
8.5.1 Latin America digital pathology market estimates and forecasts, 2014 - 2026 (USD Million)
8.5.2 Mexico
8.5.2.1 Mexico digital pathology market estimates and forecasts, 2014 - 2026 (USD Million)
8.5.3 Brazil
8.5.3.1 Brazil digital pathology market estimates and forecasts, 2014 - 2026 (USD Million)
8.5.4 Argentina
8.5.4.1 Argentina digital pathology market estimates and forecasts, 2014 - 2026 (USD Million)
8.6 MEA
8.6.1 MEA digital pathology market estimates and forecasts, 2014 - 2026 (USD Million)
8.6.2 South Africa
8.6.2.1 South Africa digital pathology market estimates and forecasts, 2014 - 2026 (USD Million)
8.6.3 Saudi Arabia
8.6.3.1 Saudi Arabia digital pathology market estimates and forecasts, 2014 - 2026 (USD Million)
8.6.4 Turkey
8.6.4.1 Turkey digital pathology market estimates and forecasts, 2014 - 2026 (USD Million)
8.6.5 Iran
8.6.5.1 Iran digital pathology market estimates and forecasts, 2014 - 2026 (USD Million)
8.6.6 United Arab Emirates
8.6.6.1 United Arab Emirates digital pathology market estimates and forecasts, 2014 - 2026 (USD Million)
8.6.7 Israel
8.6.7.1 Israel digital pathology market estimates and forecasts, 2014 - 2026 (USD Million)

Chapter 9 Company Profiles
9.1 Danaher
9.1.1 Company overview
9.1.2 Financial performance
9.1.3 Product benchmarking
9.1.4 Strategic initiatives
9.2 Hamamatsu Photonics, Inc.
9.2.1 Company overview
9.2.2 Financial performance
9.2.3 Product benchmarking
9.2.4 Strategic initiatives
9.3 Koninklijke Philips N.V.
9.3.1 Company overview
9.3.2 Financial Performance
9.3.3 Product Benchmarking
9.3.4 Strategic initiatives
9.4 Olympus Corporation
9.4.1 Company Overview
9.4.2 Financial Performance
9.4.3 Product Benchmarking
9.4.4 Strategic initiatives
9.5 F. Hoffmann-La Roche Ltd
9.5.1 Company Overview
9.5.2 Financial Performance
9.5.3 Product Benchmarking
9.5.4 Strategic Initiatives
9.6 Mikroscan Technologies
9.6.1 Company Overview
9.6.2 Product Benchmarking
9.6.2.1 Strategic Initiatives
9.7 Omnyx, LLC
9.7.1 Company Overview
9.7.2 Financial Performance
9.7.3 Product Benchmarking
9.7.4 Strategic Initiatives
9.8 Definiens
9.8.1 Company overview
9.8.2 Product benchmarking
9.8.3 Strategic initiatives
9.9 Digipath, Inc.
9.9.1 Company overview
9.9.2 Product benchmarking
9.9.3 Strategic initiatives
9.10 3DHISTECH Ltd.
9.10.1 Company overview
9.10.2 Product benchmarking

Chapter 10 Key Opinion Leader (KOL) Commentary

Chapter 11 Recommendations



*Full List of Tables and Figures Available on Enquiry.
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Danaher
  • Hamamatsu Photonics, Inc.
  • Koninklijke Philips N.V.
  • Olympus Corporation
  • F. Hoffmann-La Roche Ltd
  • Mikroscan Technologies
  • Omnyx, LLC
  • Definiens
  • Digipath, Inc.
  • 3DHISTECH Ltd.
Note: Product cover images may vary from those shown
Adroll
adroll